医学
抗抑郁药
萧条(经济学)
三环
三环类抗抑郁药
情感(语言学)
精神科
重性抑郁障碍
重症监护医学
药理学
心理学
焦虑
沟通
宏观经济学
经济
认知
作者
John A. Oates,Alastair J.J. Wood,William Z. Potter,Matthew V. Rudorfer,Husseini K. Manji
标识
DOI:10.1056/nejm199108293250907
摘要
IN the past 30 years, there have been major changes in the diagnosis and treatment of depression. Moreover, the biochemical theories of depression suggest that subgroups of patients respond to drugs that affect particular neurotransmitters, in a manner analogous to suggested subgroup responses in hypertension.1 Nonetheless, the original tricyclic antidepressant agents are still the drugs of choice for most patients with major depressive disorders.2 , 3 What follows is a review directed to creating a rational basis for selection among the available antidepressant drugs.Diagnosis of DepressionDepression is currently diagnosed according to the 1987 revision of the Diagnostic and Statistical Manual . . .
科研通智能强力驱动
Strongly Powered by AbleSci AI